** Shares of life sciences co SEER.O down 4.85% at $77.40
** Co, on Monday after-market, announced proposed public
offering of 3.5 mln shares of its Class A common
stock urn:newsml:reuters.com:*:nGNX78Z5m
** Shares on offer represent 5.89% of co's outstanding
shares
** Co to offer 1.4 mln shares, while 2.1 mln shares being
offered by selling stockholders
** Co intends to use part of the net proceeds to
commercialize the Proteograph Product Suite, and for R&D
purposes
** J.P. Morgan, Morgan Stanley, BofA Securities and Cowen
are acting as lead book-running managers for the offering
** SEER has gained 44% since its market debut on Dec. 4
(Reporting by Lasya Priya M in Bengaluru)
((LasyaPriya.M@thomsonreuters.com;))